Sunday, May 24, 2020 4:00:08 PM
I believe you're very right, and as I understand it, even Sweden, who didn't isolate, is only up to 7% community spread, that's not going to prevent it from getting worse. I do believe a therapeutic may prove to be a game changer, and I have some PSTI and believe their PLX-PAD could be it.
The fear would go away if people knew that if they get it, and they reach the stage where the get pneumonia, they'll receive the injections and the likelihood of a cure is over 95%. It was actually about 80% in the first 8 ventilator patients that received the drug, but I believe it will be much better when given before a ventilator is ever required.
If I'm right, and we should know by August, I would suspect that they'll be able to dose all ventilator patients within months, and less severe patient by roughly November. Then if we do get a vaccine by next year, the fear will be completely removed, and life can return to normal. If I'm wrong about the therapeutic, we'll wait for the vaccine to seriously get back to normal, and hopefully it will be available early next year, but it certainly could be longer.
Gary
The fear would go away if people knew that if they get it, and they reach the stage where the get pneumonia, they'll receive the injections and the likelihood of a cure is over 95%. It was actually about 80% in the first 8 ventilator patients that received the drug, but I believe it will be much better when given before a ventilator is ever required.
If I'm right, and we should know by August, I would suspect that they'll be able to dose all ventilator patients within months, and less severe patient by roughly November. Then if we do get a vaccine by next year, the fear will be completely removed, and life can return to normal. If I'm wrong about the therapeutic, we'll wait for the vaccine to seriously get back to normal, and hopefully it will be available early next year, but it certainly could be longer.
Gary
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
